State Street’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $46.6M | Buy |
|
|||||
|
2025
Q2 | $45.3M | Sell |
|
|||||
|
2025
Q1 | $52.8M | Buy |
|
|||||
|
2024
Q4 | $66.8M | Sell |
|
|||||
|
2024
Q3 | $86.2M | Buy |
|
|||||
|
2024
Q2 | $71.8M | Sell |
|
|||||
|
2024
Q1 | $118M | Buy |
|
|||||
|
2023
Q4 | $136M | Sell |
|
|||||
|
2023
Q3 | $133M | Buy |
|
|||||
|
2023
Q2 | $61.4M | Sell |
|
|||||
|
2023
Q1 | $61.5M | Buy |
|
|||||
|
2022
Q4 | $55.3M | Buy |
|
|||||
|
2022
Q3 | $4.9M | Sell |
|
|||||
|
2022
Q2 | $3.48M | Buy |
|
|||||
|
2022
Q1 | $4.61M | Sell |
|
|||||
|
2021
Q4 | $23.7M | Sell |
|
|||||
|
2021
Q3 | $35.7M | Sell |
|
|||||
|
2021
Q2 | $46.4M | Buy |
|
|||||
|
2021
Q1 | $58M | Buy |
|
|||||
|
2020
Q4 | $86.3M | Buy |
|
|||||
|
2020
Q3 | $40.5M | Buy |
|
|||||
|
2020
Q2 | $8.07M | Buy |
|